Risk factors of de novo malignancies after liver transplantation: a French national study on 11004 adult patients-Reference-Cited by-同舟云学术

Risk factors of de novo malignancies after liver transplantation: a French national study on 11004 adult patients

Published:2021-07 Issue:4 Volume:45 Page:101514
ISSN:2210-7401
Container-title:Clinics and Research in Hepatology and Gastroenterology
language:en
Short-container-title:Clinics and Research in Hepatology and Gastroenterology

Author:

Altieri Mario,Sérée Olivier,Lobbedez Thierry,Segol Philippe,Abergel Armand,Blaizot Xavier,Boillot Olivier,Boudjema Karim,Coilly Audrey,Conti Filomena,Chazouillères Olivier,Debette-Gratien Maryline,Dharancy Sébastien,Durand François,Duvoux Christophe,Francoz Claire,Gugenheim Jean^ORCID,Hardwigsen Jean,Houssel-Debry Pauline,Kamar Nassim,Latournerie Marianne,Lebray Pascal,Leroy Vincent,Neau-Cransac Martine,Pageaux Georges-Philippe,Radenne Sylvie,Salamé Ephrem,Saliba Faouzi,Samuel Didier,Vanlemmens Claire,Besch Camille^ORCID,Launoy Guy,Dumortier Jérôme

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference37 articles.

1. Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry;Adam;Liver Transpl,2003

2. Survie globale du receveur après greffe hépatique (1993-2014). Available from: https://www.agence-biomedecine.fr/annexes/bilan2015/donnees/organes/2005-foie/synthese.htm (consulted the June 10, 2019).

3. De novo malignancies after liver transplantation: a major cause of late death;Fung;Liver Transpl,2001

4. De novo cancer-related death in Australian liver and cardiothoracic transplant recipients;Na;Am J Transplant,2013

5. Long-term probability of and mortality from de novo malignancy after liver transplantation;Watt;Gastroenterology,2009

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Malignancy After Living Donor Liver Transplantation;Transplantation Proceedings;2024-04

2. Epidemiology of Bladder Cancer in 2023: A Systematic Review of Risk Factors;European Urology;2023-08

3. The Role of mTOR Inhibitors after Liver Transplantation for Hepatocellular Carcinoma;Current Oncology;2023-06-09

4. De Novo Malignancy After Adult-to-Adult Living Donor Liver Transplantation: A Single-Center Long-Term Experience;Transplantation Proceedings;2023-05

5. Which liver transplant patients will become octogenarians? A French single-center study;Clinics and Research in Hepatology and Gastroenterology;2023-03